Voloridge Investment Management
ZYME icon

Voloridge Investment Management’s Zymeworks ZYME Stock Holding History

Voloridge Investment Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-95,394
Closed -$1.14M – 1426
2025
Q1 		$1.14M Buy
95,394
+51,686
+118% +$705K ﹤0.01% 1033
2024
Q4 		$640K Buy
+43,708
New +$611K ﹤0.01% 1083
2023
Q3 		– Sell
-90,803
Closed -$785K – 1638
2023
Q2 		$785K Sell
90,803
-162,401
-64% -$1.45M ﹤0.01% 1161
2023
Q1 		$2.29M Buy
253,204
+211,383
+505% +$1.84M 0.01% 941
2022
Q4 		$329K Sell
41,821
-248,789
-86% -$1.75M ﹤0.01% 1332
2022
Q3 		$1.79M Sell
290,610
-103,309
-26% -$623K 0.01% 1014
2022
Q2 		$2.09M Sell
393,919
-86,457
-18% -$523K 0.01% 1003
2022
Q1 		$3.15M Buy
480,376
+348,219
+263% +$3.1M 0.02% 804
2021
Q4 		$2.17M Buy
+132,157
New +$2.76M 0.01% 1043
2021
Q2 		– Sell
-19,577
Closed -$618K – 1823
2021
Q1 		$618K Buy
19,577
+13,980
+250% +$568K ﹤0.01% 1138
2020
Q4 		$265K Buy
+5,597
New +$260K ﹤0.01% 1240

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Voloridge Investment Management's ZYME Position: Q2 2025 in Review

Voloridge Investment Management sold out of Zymeworks (ZYME) in Q2 2025, closing a stake of 95,394 shares — an estimated $1.14M sold.

Voloridge Investment Management first reported a position in ZYME in Q4 2020 and held it in 11 quarters. The position peaked at $3.15M in Q1 2022. 181 funds tracked by Wall St. Rank hold ZYME as of Q2 2025.

  • Voloridge Investment Management reported no remaining Zymeworks position as of Q2 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 95,394 Zymeworks shares in Q2 2025, an estimated $1.14M.
  • Voloridge Investment Management first reported a position in Zymeworks in Q4 2020 and held it in 11 quarters.
  • Voloridge Investment Management's Zymeworks position peaked at $3.15M in Q1 2022.
  • 181 funds tracked by Wall St. Rank held Zymeworks as of Q2 2025.

Based on Voloridge Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.